  See all
 |
Articles: Lung/Thoracic Oncology |
Prior Articles
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: CCTGcctg and SWOG study N0426
Journal of Clinical Oncology, 10/26/09 Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer
Cancer, 10/26/09
Exclusive Author Commentary State-of-the-art lung cancer radiation therapy
Expert Review of Anticancer Therapy, 10/26/09 Influence of Narrow Band Imaging (NBI) Videobronchoscopy on the Assessment of Central Lung Cancer Extension and Therapeutic Decision
Cancer Investigation, 10/26/09 Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation, 10/23/09 Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
Cancer Science, 10/23/09 Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Cancer Science, 10/23/09 Radiochemotherapy in the elderly with lung cancer
Expert Review of Anticancer Therapy, 10/22/09 Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer
Human Pathology, 10/22/09 Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy
Expert Review of Anticancer Therapy, 10/22/09 Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue
Expert Review of Anticancer Therapy, 10/22/09 Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma
Cancer Epidemiology, 10/22/09 Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced NSCLC
Journal of Clinical Oncology, 10/20/09 A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405
Annals of Oncology, 10/20/09 Radiochemotherapy in small-cell lung cancer
Expert Review of Anticancer Therapy, 10/20/09 Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer
Annals of Oncology, 10/20/09 Combination of radiotherapy and chemotherapy in locally advanced NSCLC
Expert Review of Anticancer Therapy, 10/20/09 Reconstitution of Amphiregulin–Epidermal Growth Factor Receptor Signaling in Lung Squamous Cell Carcinomas Activates PTHrP Gene Expression and Contributes to Cancer-Mediated Diseases of the Bone
Molecular Cancer Research, 10/20/09
Exclusive Author Commentary Amplification of Lipopolysaccharide-Induced Cytokine Synthesis in Non–Small Cell Lung Cancer/Neutrophil Cocultures
Molecular Cancer Research, 10/20/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
